Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT Study (COLT)

This study is ongoing, but not recruiting participants.
Information provided by:
Nantes University Hospital Identifier:
First received: September 11, 2009
Last updated: May 11, 2015
Last verified: May 2015
Obliterative Bronchiolitis (OB) is the major cause of long-term lung allograft loss for patients with end stage pulmonary diseases like cystic fibrosis. Numerous cells and proteins are implicated in this process, which have never been studied prospectively in a multicentric longitudinal cohort. The aim of this study is to detect predictive risk factors of OB through a national multicentric cohort of 500 newly transplanted recipients (COLT). COLT will consist in a large database, associated with a recipient bio-collection, and specific projects using these resources. COLT will aggregate all the 11 French centres of pulmonary transplantation. Patient will be followed-up during 5 years. Blood samples will be obtained. Induced sputum, bronchoalveolar lavage fuid, exhaled breath condensate and trans bronchial biopsies will be also taken. T cells, known to be involved in chronic rejection will be studied, and genomic, microarray and proteomic approaches will be used to detect further predictive factors. A study on Circulating Endothelial Cells and Circulating Endothelial Progenitors is also realised from blood samples. COLT will prove molecular markers to be predictive of early OB, before the development of severe airway obstruction and will allow the identification of patients at high risk of OB. COLT will identify potential targets for future treatments of OB. This collaborative project makes research and clinical teams working together, and creates the conditions of a long term network, extendable to other laboratories with new projects and additional European transplant centres.

Condition Intervention
Chronic Rejection
Lung Transplantation
Other: Study of predictive factors

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Predictive Factors for Chronic Rejection in Lung Transplant Recipients: COLT Study

Resource links provided by NLM:

Further study details as provided by Nantes University Hospital:

Primary Outcome Measures:
  • Identification of predictive factors for lung chronic rejection outcome in lung transplant recipients. This primary outcome will be evaluated at the end of the study. [ Time Frame: 8 years ]

Secondary Outcome Measures:
  • Evaluate the pertinence of a monitoring of lung chronic rejection based on the predictive factors identified in the study, in order to prevent this rejection. The secondary outcome measure will be evaluated at the end of the study. [ Time Frame: 8 years ]

Enrollment: 700
Study Start Date: September 2009
Estimated Study Completion Date: September 2017
Estimated Primary Completion Date: September 2017 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Study of predictive factors
    Identification of predictive factors for lung chronic rejection outcome in lung transplant recipients

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Male or female adults aged ≥ 18 years
  • who have signed an Inform Consent Form
  • double or heart-lung transplant recipients

Exclusion Criteria:

  • Pregnant or nursing women
  • Patients with concomitant chronic inflammatory disease, independently of acute or chronic rejection or infection
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00980967

CHU de Bordeaux
Bordeaux, France, 33604
CHU de Grenoble
Grenoble, France, 38700
Centre Chirurgical Marie Lannelongue
Le Plessis-Robinson, France, 92350
CHU de Lyon
Lyon, France, 69677
CHU de Marseille
Marseille, France, 13015
CHU Nantes
Nantes, France, 44093
Paris, France, 75015
Hôpital Bichat
Paris, France, 75018
CHRU de Strasbourg
Strasbourg, France, 67091
Hôpital Foch
Suresnes, France, 92150
CHU de Toulouse
Toulouse, France, 31059
Sponsors and Collaborators
Nantes University Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: CHU de Nantes Identifier: NCT00980967     History of Changes
Other Study ID Numbers: BRD 09/1-F
Study First Received: September 11, 2009
Last Updated: May 11, 2015

Keywords provided by Nantes University Hospital:
Lung transplantation
Chronic lung rejection
Obliterative bronchiolitis
Predictive factors processed this record on May 25, 2017